Skip to content

Christopher R Mccurdy

Department of Medicinal Chemistry, College of Pharmacy, The University of Florida, Gainesville, FL 32610, USA.

3 papers in the library · 87 citations · publishing 0-2012

Papers

The hallucinogen derived from Salvia divinorum, salvinorin A, has kappa-opioid agonist discriminative stimulus effects in rats.

Neuropharmacology September 1, 2007 Catherine B Willmore-Fordham, Daniel M Krall, Christopher R Mccurdy et al. 49 citations

Salvinorin A, a plant-derived hallucinogen, acts through the kappa-opioid receptor system, producing effects such as pain relief, sedation, dysphoria, and distorted perceptions. In experiments with male rats trained to recognize a known kappa-opioid agonist, salvinorin A fully substituted for that agonist at three different doses without altering response rates. A kappa-selective antagonist blocked this substitution, confirming the receptor mechanism. These findings support salvinorin A's potential for therapeutic developments, including pain relief, while also raising public concern about its misuse.

Antidepressive effects of the κ-opioid receptor agonist salvinorin A in a rat model of anhedonia.

Behavioural pharmacology October 1, 2012 Mitchell T Harden, Staci E Smith, Jennifer A Niehoff et al. 37 citations

Salvinorin A (SalvA), a compound from the plant Salvia divinorum that activates κ-opioid receptors, may have antidepressant effects. In a study using male and female Long-Evans rats, chronic mild stress (CMS) for three weeks reduced their preference for sucrose water, indicating anhedonia, a key symptom of depression. After three more weeks of CMS, rats given daily injections of 1 mg SalvA per kilogram of body weight showed a reversal of this anhedonia, while control rats did not. Nonstressed rats given the same dose showed no change in sucrose preference. The findings suggest that chronic SalvA treatment acts as an effective antidepressant in this animal model.

A Pilot, Dose-Finding, Pharmacodynamic and Pharmacokinetic Study of Orally Administered Botanical Kratom.

Journal of clinical psychopharmacology Chad J Reissig, Ling Chen, Srikanth C Nallani et al. 1 citation

A single dose of kratom, a plant from Southeast Asia, produced some opioid-like effects in recreational polydrug users with opioid experience. In a double-blind, placebo-controlled study with 40 participants, kratom at doses of 3 grams or more caused pupil constriction, and the 12 gram dose increased ratings of drug liking, good effects, and high. No deaths or serious adverse events occurred; the most common side effects were somnolence, vomiting, and nausea. The findings suggest kratom can produce effects associated with drugs of abuse, but results may not apply to other kratom products.